Effectiveness of intravitreal chemotherapy-assisted endoresection in monocular patients with group D retinoblastoma

Table 1 Characteristics of patients with ICRB group D retinoblastoma underwent intravitreal chemotherapy-assisted endoresection

No.	Age (months)	Vitreous seeds Classification^a	Subretinal seeds	Retinal detachment	TMN Classification^b	Treatment history
01	36	Dust	Y	Y	cT2bN0M0H1	IVC + IViC
02	48	Dust	Y	Y	cT2bN0M0H1	IVC + IViC
03	8	Dust	Y	N	cT2bN0M0H1	IVC + IViC
04	30	Dust	Y	N	cT2bN0M0H1	IVC + IViC
05	24	Dust	Y	N	cT2bN0M0H1	IVC + IViC
06	78	Dust	Y	N	cT2bN0M0H1	IVC + IViC
07	71	Dust	Y	N	cT2bN0M0H1	IVC + IViC
08	65	Cloud	Y	N	cT2bN0M0H1	IVC + IViC
09	88	Cloud	Y	Y	cT2bN0M0H1	IVC + IViC
10	31	Spheres	Y	N	cT2bN0M0H1	IVC + IAC + IViC
11	29	Spheres	Y	Y	cT2bN0M0H1	IVC + IViC

IVC Intravenous chemotherapy, IViC Intravitreal chemotherapy, IAC Intra-arterial chemotherapy
^aVitreous seeding was classified by the criteria of Francis, J. H. et al. [11]
^bAccording to the 8th edition American Joint Committee on Cancer/Union for International Cancer Control Clinical Staging System (8th ed. cTNMH)

ISSN: 1471-2407